Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 28 Sep 2021  |  Global

    Global Automated Endoscope Reprocessors (AER) Growth Opportunities

    Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies

    While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation. The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automate...

    $4,950.00
  2. 28 Sep 2021  |  Global

    Global Automated Endoscope Reprocessors (AER) Growth Opportunities

    Breakthrough Technologies and Strategic Collaborations Drive Growth Strategies

    While the entire healthcare industry adapts to changes induced by the COVID-19 pandemic, the endoscope reprocessing industry undergoes a major technology transformation. The rise in multiple infection outbreaks from contaminated endoscopes due to faulty endoscope reprocessing and manual errors in cleaning presents huge growth potential for automate...

    $4,950.00
  3. 28 Sep 2021  |  Global

    Global Healthcare Cloud Growth Opportunities

    Competitive Intensity Drives the Growth Potential of Hybrid and Multi-cloud Deployment Models

    The COVID-19 pandemic has shown that many healthcare organizations do not have the necessary agility and business continuity programs or technologies to support them during crises. It is forcing businesses to act on cloud and digital transformation strategies that they had been delaying until now. The cloud is more critical than ever in helping...

    $4,950.00
  4. 20 Sep 2021  |  North America

    Global In Vitro Diagnostics Market Outlook, 2021

    Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic

    The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...

    $4,950.00
  5. 13 Sep 2021  |  North America

    Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

    Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

    This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of...

    $4,950.00
  6. 09 Sep 2021  |  North America

    Global Medical Device Leasing Growth Opportunities

    Vendors' Integration of Support Services and Shift from Product-centric to Value-oriented Business Models will Improve ROI and Mar

    Globally, hospitals and health systems face financial pressure caused by high operating and administrative costs, declining revenue and reimbursement rates, and the increasing cost of both medical devices (due to technology advancements) and infrastructure. The COVID-19 pandemic has intensified this financial crisis as patient volumes dropped and n...

    $2,450.00
  7. 03 Sep 2021  |  North America

    Global Renal Care Management Growth Opportunities

    Value-based Renal Care to be a Key Growth Area

    The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...

    $4,950.00
  8. 31 Aug 2021  |  Global

    Research Efforts Fuel the Future of Global Obstructive Lung Disease Management

    Technology Developments Driving Transformational Growth in Treatment Modalities for Obstructive Lung Diseases

    Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

    $4,950.00
  9. 27 Aug 2021  |  North America

    US and EU Upstream Bioprocessing Growth Opportunities

    Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing

    The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

    $4,950.00
  10. 24 Aug 2021  |  North America

    US and EU Biotech Industry VC Investment Growth Opportunities

    Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

    With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

    $2,450.00